Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-30

Clinical Trial Update: Wisconsin Ginseng for Decreasing Cancer Related Fatigue [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Wisconsin Ginseng for decreasing cancer-related fatigue in patients with malignant solid tumors. The study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Wisconsin Ginseng

Snippet

Sponsor: Mayo Clinic | Conditions: Malignant Solid Neoplasm | Phase 3 | Status: RECRUITING